MedPath

An open label clinical trial to evaluate the efficacy of Vamana Karma ( Emesis) in the management of Urdhwaga Amalpitta (Hyperacidity and Gastritis ).â€

Phase 3
Not yet recruiting
Conditions
Acute gastritis. Ayurveda Condition: URDHVAGATA-AMLAPITTAM,
Registration Number
CTRI/2023/03/050890
Lead Sponsor
Shri Krishna Government Ayurvedic College and Hospital kurukshetra
Brief Summary

Nowadays *Pitta Vardhaka Ahar Vihar* is becoming major part of present life style excessive intake of junk food, salty, spicy & fried food, frequent use of NSAIDs, antibiotics, steroids and aspirin like medicines and *vihar* like fasting, eating between the meals( *adhyashan*), having food in hurry & worry, suppression of urges, derange the *pachak* pitta thus developing a condition called *amlapitta*. Prakrita rasa of pitta is bitter ( *katu*). *Amlapitta* is a condItion where prakrita rasa of pitta changes from bitter to sourer. 

*Amlapitta* is characterized by *aruchi* (anorexia), *gurukosthatva* ( heaviness in abdomen), *klama* ( lethargy), *vibandh* ( constipation), *shiroruja* ( headache ), *hrutakanthadaha* ( burning sensation in chest ), *tiktoamlaudgara* ( bitter and sour belching ) as general symptoms ).

*Acharya Charak* in *Charak Samhita* has not described *amlapitta* as a disease. He has mentioned that when *annavisha* combines with pitta & *amlapitta* occurs. Acharya *Madhava* & *Acharya Kashyap* described the disease in detail and classified it on the basis of *gati* i.e., ( *urdhwaga amlapitta & adhoga amlapitta*) and *sansarga of dosha* ( *sanila amlapitta* & *sanila kaphaja amlapitta*).

Sign and symptoms of *amlapitta* is very similar to gastritis and hyperacidity.

*Vaman karma* is a treatment of choice for the *urdhwaga amlapitta* as mentioned in the *Bhaishjyaratnavali.*

In *urdhwagaamlapitta* vititated pitta and kapha are the key factors responsible for whole Pathological process. *Vaman karma* is indicated as *shodhana karma* for urdhawaga *amlapitta.* The symptoms of *urdhwaga amlapitta* are due to the disturbance in *dravata* and *ushnata* of *pachak pitta* and *snigdhata* of *kledak kapha*. *Vaman* is found to be effective in *urdhawga amlapitta* which is *amashaya janya vyadhi* and in *vaman amashaystha doshas* are expelled out.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients having classical sign and symptoms of Urdhwaga Amlapitta as per Ayurvedic classics.
  • Patient having cardinal symptoms of gastritis and hyperacidity with the duration not more than one year.
  • Male or female between the age group 25- 50 year.
  • Patients who are fit for Vaman Karma as per ayurvedic classics.
Exclusion Criteria
  • Patients below 25 years and above 50 years.
  • Patients of Amlapitta with any chronic system disease which interferes with the present study.
  • Patients suffering from any current acute illness.
  • Patients having associated complicated systemic disorders like cardiac diseases, diabetes, tuberculosis, bronchial asthma, autoimmune diseases etc.
  • Known case of gastric and duodenal ulcer.
  • Known case of gastric carcinoma.
  • Chronic gastritis (more than one year) 8.
  • Hiatus hernia, Barrett’s esophagus.
  • Patients with the previous history of hematemesis, hemoptysis or melena.
  • Patients having congenital physiological anomalies, surgical interventions, and any trauma.
  • Patients who are contraindicated for Vaman Karma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary outcome Relieve in the sign and symptoms of Urdhwaga Amlapitta as per subjective criteriaat the baseline of 20th 40th & 60th day
Secondary Outcome Measures
NameTimeMethod
➢ The lifestyle of patient improved after the treatment. Patient can perform daily routineactivity without any trouble.

Trial Locations

Locations (1)

shri krishna gov. ayurvedic college and hospital

🇮🇳

Kurukshetra, HARYANA, India

shri krishna gov. ayurvedic college and hospital
🇮🇳Kurukshetra, HARYANA, India
Neetu chauhan
Principal investigator
09927044063
neetuharidwar1@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.